Oncolytics Biotech Inc.
ONCY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $299 | $301 | $361 |
| Gross Profit | $0 | -$299 | -$301 | -$361 |
| % Margin | – | – | – | – |
| R&D Expenses | $21,647 | $13,121 | $11,854 | $10,306 |
| G&A Expenses | $13,335 | $0 | $0 | $0 |
| SG&A Expenses | $13,335 | $11,617 | $8,526 | $10,259 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $34,982 | $24,738 | $20,380 | $20,565 |
| Operating Income | -$34,982 | -$25,036 | -$20,681 | -$20,925 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $3,402 | $4,546 | $1,669 | -$16 |
| Pre-Tax Income | -$31,580 | -$20,490 | -$19,012 | -$20,941 |
| Tax Expense | $130 | $72 | $65 | $39 |
| Net Income | -$31,710 | -$20,562 | -$19,077 | -$20,981 |
| % Margin | – | – | – | – |
| EPS | -0.41 | -0.41 | -0.43 | -0.49 |
| % Growth | 0% | 4.7% | 12.2% | – |
| EPS Diluted | -0.41 | -0.41 | -0.43 | -0.49 |
| Weighted Avg Shares Out | 76,482 | 67,624 | 58,030 | 53,513 |
| Weighted Avg Shares Out Dil | 76,483 | 67,624 | 58,030 | 53,513 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,199 | $1,326 | $528 | $99 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $102 | $299 | $301 | $361 |
| EBITDA | -$34,880 | -$20,191 | -$18,711 | -$20,581 |
| % Margin | – | – | – | – |